Tap into these tips to make your company safer from cyber attacks. Photo via Getty Images

Imagine waking up tomorrow to find out that all of your critical information (trade secrets, financial data, customer lists, etc.) is gone. While working to find out what happened, you order lunch online, only to find out your bank account has no balance.

That scenario happens every day to business leaders just like you. Here are 5 tips everyone should know, which will help reduce cyber security risks.

Tip 1: Know what you need to protect

If you don’t know where your data is kept, how can you protect it?

From hardware like laptops and cell phones, to critical software including accounting and HR, spreadsheets used to calculate financial reports, OneDrive accounts, Google Drive, and “C” drives, there are numerous places your critical data could be kept. Work with your managers to identify every piece of hardware, software, and where the critical data is kept.

Tip 2: Turn on multi-factor authentication for everything you possibly can.

Whenever possible, someone should need a username, password, and a code from an authentication app, text code, e-mailed code, something that’s a unique identifier that randomly changes in order to access critical company information. Alternatively, you can rely on biometrics (fingerprints, facial recognition, etc.) as your third line of protection.

Tip 3: Know who has access to the data and implement basic user access rules.

Everyone should have their own username and unique password. Generic admin accounts, shared user accounts, etc. should never be allowed. If you’re only paying for five licenses but have 10 people accessing the software, stop being cheap and pay for more licenses.

Log in to your bank’s website (or go to a local branch) and run a report which lists who has access to the online banking system and what they can do within it. While you’re at it, get a report of everyone with signature rights for checks and make sure it’s properly updated.

Run a report of all users for each software you listed above which includes what level of access they have. Does their access match their job requirements? Remove all access that isn’t required for their job. You can add access back later if they need it. This can also help you identify employees who might have too many responsibilities.

Now go through the rest of the software, network folders, and the other items you listed above and do the same exercise. Going forward, whoever “owns” the data in each system (banking, accounting, HR, etc.) should approve all access to that data.

Tip 4: Back up that data — often

You most likely have a folder on your computer that has important information in it like Financial spreadsheets, HR files, customer data, and marketing plans. If you selected that folder and hit the delete key, then you opened the recycle bin on your desktop and the folder wasn’t there, how bad would your day be?

Now that you know the location of files, folders, software, and other important data points, turn on an auto-backup process and test that process about once a quarter. If you use something like Google Drive, Microsoft’s OneDrive, or similar cloud services, most will provide free backup support. However, before you do that, require all employees to move important files off of their “C” drive and into network folders.

Tip 5: Implement antivirus software

I’ll be the first to say that I hate antivirus software. Why? Because it typically slows down your computer while it runs in the background and flags items like the spreadsheet you use every month as a “potential threat”.

Even so, the aggravation is worth it in the long run.

There are tons of antivirus software options. If you think about protecting your home, you don’t need armed guards, attack dogs, and a feral cat. You do need someone to glance out the window to see who is at the door. If it’s a group of zombies trying to eat you, then you need to have the ability and resources to protect your home. Pick an antivirus software that matches your budget and get it in place. Don’t overthink it, just get it going.

One last bonus tip I’ll leave you with — have random test “phishing” emails sent out to everyone (including yourself) in your company. The number one cause of cyber security issues in businesses is internal users clicking on fake emails.

------

Thomas Mullinnix is the founder of Houston-based Re-Vision Management Consulting LLC.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.